Tilray is strong for a number of reasons: mostly, because its profitability isn't tied to legalisation at the US federal level. Obviously, that would rocket the price; but even if it doesn't, it has strong goings in CA, and is picking up strongly in the medical cannabis market in various EU countries, so there is profitability there too.